Hypoxia Methylome Classifier (HDMC) Outperforms Gene Signatures in Identifying HPV-Negative HNSCC Patients at Risk for Locoregional Failure Post Primary Radiochemotherapy: A German Cancer Consortium Radiation Oncology Group (DKTK-ROG) Multicenter Trial.
Saved in:
| Title: | Hypoxia Methylome Classifier (HDMC) Outperforms Gene Signatures in Identifying HPV-Negative HNSCC Patients at Risk for Locoregional Failure Post Primary Radiochemotherapy: A German Cancer Consortium Radiation Oncology Group (DKTK-ROG) Multicenter Trial. |
|---|---|
| Authors: | Tawk, B.1 (AUTHOR), Wirkner, U.1 (AUTHOR), Schwager, C.1 (AUTHOR), Herpel, E.2 (AUTHOR), Tinhofer, I.3 (AUTHOR), Budach, V.3 (AUTHOR), Krause, M.4 (AUTHOR), Stuschke, M.5 (AUTHOR), Balermpas, P.6 (AUTHOR), Roedel, C.7 (AUTHOR), Grosu, A.8 (AUTHOR), Zips, D.9 (AUTHOR), Combs, S.E.10 (AUTHOR), Weichert, W.11 (AUTHOR), Belka, C.10 (AUTHOR), Baumann, M.1 (AUTHOR), Herold-Mende, C.12 (AUTHOR), Debus, J.1 (AUTHOR), Abdollahi, A.1 (AUTHOR) |
| Source: | International Journal of Radiation Oncology, Biology, Physics. 2020 Supplement, Vol. 108 Issue 3, pe552-e553. 2p. |
| Subjects: | Hypoxemia, Chemoradiotherapy, Oncology, Cancer, Consortia |
| Database: | Engineering Source |
Be the first to leave a comment!
